Adderall Dosage Calculator
Calculate appropriate Adderall (amphetamine) dosage by age, weight, and formulation. Includes titration schedules, IR vs XR guidance, and safety reference tables.
Calculate tramadol dosing by weight with renal, hepatic, and elderly adjustments. Includes MME conversion, serotonin syndrome risk, seizure warnings, and drug interaction tables.
| Population | Starting Dose | Titration | Max Daily | Interval |
|---|---|---|---|---|
| Adult (IR) | 25 mg/day | โ25 mg q3 days | 400 mg | q4โ6h |
| Adult (ER) | 100 mg once daily | โ100 mg q5 days | 300 mg | q24h |
| Elderly (โฅ65) | 25 mg q12h | โ25 mg q5โ7 days | 300 mg | q6โ8h |
| Renal (CrCl <30) | 50 mg q12h | Cautious | 200 mg | q12h |
| Hepatic (cirrhosis) | 50 mg q12h | Cautious | 200 mg | q12h |
| Drug/Class | Interaction | Risk |
|---|---|---|
| SSRIs (fluoxetine, sertraline) | Serotonin syndrome | High |
| SNRIs (venlafaxine, duloxetine) | Serotonin syndrome | High |
| MAOIs | Serotonin syndrome โ CONTRAINDICATED | Severe |
| Benzodiazepines | Respiratory depression | High |
| CYP2D6 inhibitors (quinidine) | Reduced analgesia (blocks active metabolite) | Moderate |
| CYP3A4 inhibitors (ketoconazole) | Increased tramadol levels | Moderate |
| Seizure-lowering drugs | Additive seizure risk | Moderate |
The Tramadol Dosage Calculator determines appropriate tramadol doses based on weight, patient population, and formulation, with adjustments for renal impairment, hepatic disease, elderly patients, and CYP2D6 ultra-rapid metabolizers. Tramadol (brand name Ultram) is a unique centrally acting analgesic with dual mechanisms: weak mu-opioid receptor agonism and inhibition of serotonin and norepinephrine reuptake.
This dual mechanism makes tramadol both versatile and potentially dangerous. The opioid component provides analgesia but carries risks of dependence, respiratory depression, and misuse. The serotonergic component adds analgesic and antidepressant-like effects but creates a serious risk of serotonin syndrome when combined with SSRIs, SNRIs, triptans, or MAOIs. Additionally, tramadol uniquely lowers the seizure threshold, especially at doses above 400 mg/day or in patients with epilepsy.
This calculator accounts for all major dose-limiting factors: maximum daily limits by formulation type, renal dose reduction for CrCl below 30 mL/min, hepatic dose reduction for cirrhosis, conservative elderly dosing, morphine milligram equivalent (MME) calculation for opioid monitoring, and risk flags for serotonin syndrome and seizure susceptibility. It includes presets for common clinical scenarios and drug interaction reference tables.
Tramadol dosing is easy to overestimate because analgesia, seizure risk, serotonin toxicity, and organ-function adjustments all change the safe range. This calculator keeps those limits visible together so prescribers can compare the selected dose against renal, hepatic, and age-based constraints before writing it down.
Adult IR: 50โ100 mg q4โ6h (max 400 mg/day)
Adult ER: 100โ300 mg once daily (max 300 mg/day)
Elderly: max 300 mg/day
Renal (CrCl <30): max 200 mg/day, q12h interval
Hepatic (cirrhosis): max 200 mg/day, IR only
MME = Tramadol dose ร 0.1Result: 200 mg/day (50% of 400 mg max); MME = 20; Standard risk profile
A 70 kg adult taking 50 mg tramadol IR four times daily totals 200 mg/day, which is 50% of the 400 mg maximum. The morphine milligram equivalent (MME) is 20 (200 ร 0.1), well below the 50 MME monitoring threshold.
Tramadol's analgesia comes from two distinct mechanisms working synergistically. The parent compound weakly inhibits serotonin and norepinephrine reuptake, while its hepatic metabolite O-desmethyltramadol (M1, produced by CYP2D6) has 200ร the mu-opioid receptor affinity of the parent drug. This means tramadol's opioid effect depends heavily on CYP2D6 activity: poor metabolizers get little opioid effect (tramadol may be ineffective), while ultra-rapid metabolizers produce excess M1 (risk of respiratory depression).
Serotonin syndrome from tramadol + serotonergic drugs presents with a triad: altered mental status (agitation, confusion), autonomic instability (hyperthermia, tachycardia, hypertension, diaphoresis), and neuromuscular abnormalities (clonus, hyperreflexia, tremor, rigidity). The Hunter Criteria provide a clinical decision rule: serotonin syndrome is likely if the patient takes a serotonergic drug AND has spontaneous clonus, or inducible clonus plus agitation/diaphoresis, or ocular clonus plus agitation/diaphoresis, or tremor plus hyperreflexia. Treatment includes stopping the offending agents, benzodiazepines for agitation, and cyproheptadine (serotonin antagonist) for moderate-to-severe cases.
Tramadol was initially believed to have relatively low abuse potential, which contributed to its widespread prescribing. However, real-world data showed meaningful rates of dependence and misuse, so it should still be handled with the same monitoring mindset applied to other opioids. Prescription Drug Monitoring Programs (PDMPs) and CDC opioid-risk thresholds still matter in that broader context. At tramadol's 0.1 conversion factor, 50 MME/day corresponds to 500 mg/day, which already exceeds the usual 400 mg/day maximum, so tramadol alone rarely crosses that threshold.
Last updated:
This worksheet compares labeled tramadol dose limits and converts them into daily totals and morphine milligram equivalent context.
For immediate-release: 400 mg/day for healthy adults. For extended-release: 300 mg/day. These limits are lower for elderly (300 mg), renal impairment (200 mg), and hepatic impairment (200 mg). Never exceed these limits due to seizure risk.
Yes. Tramadol inhibits serotonin reuptake and can cause serotonin syndrome when combined with SSRIs, SNRIs, MAOIs, triptans, lithium, or other serotonergic drugs. Symptoms include agitation, hyperthermia, clonus, tremor, and altered mental status. This combination is a common cause of drug-induced serotonin syndrome.
Tramadol lowers the seizure threshold, particularly at doses above 400 mg/day, in patients with epilepsy, during alcohol/benzo withdrawal, or when combined with other seizure-lowering drugs. The risk is approximately 0.5% at therapeutic doses but increases significantly with overdose.
Tramadol is weaker than most opioids โ its MME conversion factor is 0.1 (tramadol 100 mg โ morphine 10 mg). However, it has unique risks (seizures, serotonin syndrome) that stronger opioids lack. It is not a safe substitute in opioid-tolerant patients.
Tramadol and its active metabolite (M1, O-desmethyltramadol) are excreted renally. In severe renal impairment (CrCl <30 mL/min), the half-life extends from 6 hours to 11+ hours, causing accumulation. The dose should be halved and the interval extended to every 12 hours.
About 1โ7% of people (higher in certain ethnic groups) carry multiple CYP2D6 gene copies, converting tramadol to its active opioid metabolite (M1) much faster than normal. This can lead to unexpectedly strong opioid effects, respiratory depression, and even death. Genetic testing is available.
Calculate appropriate Adderall (amphetamine) dosage by age, weight, and formulation. Includes titration schedules, IR vs XR guidance, and safety reference tables.
Calculate Aleve (naproxen sodium) dosing by age, weight, and condition. Includes OTC max limits, dosing schedules, risk factors, and safety reference tables.
Calculate pediatric amoxicillin doses by weight, indication, and formulation. Includes suspension volume, dosing schedules, and indication-specific reference tables.